search
Back to results

Pain Treatment in a Breast Cancer Population. PaiNEd Study. (PaiNEd)

Primary Purpose

Breast Cancer

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Multimodal rehabilitation program + PNE (Therapeutic exercise, manual therapy and PNE)
Multimodal rehabilitation program + traditional biomedical information
Control group
Sponsored by
Universidad de Granada
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Cancer focused on measuring E-health, exercise, telehealth, telerehabilitation, pain management, cancer

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Subjects over 18 years of age.
  2. Having undergone surgery and finished adjuvant treatment (radiotherapy and / or chemotherapy) six months or two years ago.
  3. Not having active cancer.
  4. Having pain in the regions related to the tumor area (cervical and / or brachial and / or shoulder), pain ≥ 4 (VAS 0 to 10) for> 4 weeks
  5. Present musculoskeletal or functional alterations in the previous regions.

Exclusion Criteria:

  1. Identification by the research team of physical or mental impossibility to carry out the tests of the study.
  2. Suffering from chronic pain or having suffered a previous trauma to the spine, head, temporomandibular joint or upper extremities.

Sites / Locations

  • Health Sciences Faculty, University of GranadaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Multimodal rehabilitation program + PNE (Therapeutic exercise, manual therapy and PNE)

Multimodal rehabilitation program + traditional biomedical information

Control group

Arm Description

Physical recovery program (multimodal) with a duration of 8 weeks. Three weekly sessions on alternate days lasting 60 minutes each one. 4 individual manual therapy sessions (1 session every 2 weeks). Access to the PaiNEd system.

Physical recovery program (multimodal) with a duration of 8 weeks. Three weekly sessions on alternate days lasting 60 minutes each one. 4 individual manual therapy sessions (1 session every 2 weeks). Dossier with traditional biomedical recommendations on the management of pain and disability.

Information dossier with recommendations on pain control and dysfunction improvement.

Outcomes

Primary Outcome Measures

Change from baseline in Pain on the Visual Analogue scale and Brief Pain Inventory at 2 and 6 months.
The Visual Analogue Scale is used to assess the intensity of spontaneous neck, temporomandibular and shoulder pain. The VAS is a 100 mm line anchored with a '0' at one end representing no pain and '100' at the other end representing the worst pain imaginable.

Secondary Outcome Measures

Changes from baseline in Pain Catastrophizing Scale at 2 and 6 months.
Used to assess catastrophic thinking related to pain. Pain catastrophizing scale is a 13-item self-reported questionnaire. Patients rate how frequent they experience each of 13 items or types of pain experience. It uses a 5-point Likert scale, from 0 (mild symptoms) to 4 (worst symptoms). The total score is derived from the sum of the individual scores for the 13 items. The higher the total score, the more the patient exhibits pain catastrophizing characteristics.
Changes from baseline in Central Sensitization Inventory (CSI) at 2 and 6 months.
Used to assess if participants have symptoms that may be related to central sensitisation. The Central Sensitization Inventory (CSI) is composed of two different parts. The first one consists of 25 statements, each answer is scored: 0 Never, 1 Rarely, 2 Sometimes, 3 Often, and 4 Always. So that, at most we will be able to obtain a score of 100 and a minimum of 0. The second part is a survey in which patients explain if they have been diagnosed of specific disorders. Higher CSI scores mean greater symptoms of central sensitization. If patients obtain a score greater than or equal to 40, we will consider that they have sufficient psychometrics to be correlated with central sensitization syndromes
Changes from baseline in Kinesiophobia on the Tampa Scale for Kinesiophobia (TSK-11) at 2 and 6 months.
Kinesiophobia will be measured by an 11-item version of the Tampa Scale for Kinesiophobia (TSK-11). Each item has 4 response options, "strongly disagree" scores 1 point, and "strongly agree" scores 4 points. The maximum possible score is 44 points and the minimum is 11 points. Greater scores mean strong fear of movement.
Changes from baseline in Active shoulder and cervical spine on goniometry at 2 and 6 months.
A plastic universal goniometer with two adjustable overlapping arms is used to objectively measure the active range of motion of the shoulder joint. An inclinometer device is used to objectively measure the active range of motion of the cervical joints.
Changes from baseline in Quality of life on The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire at 2 and 6 months.
This questionnaire is a breast cancer module of the The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire that contains 23 items rated on a four-point scale ranging from 1 (not at all) to 4 (very much). The items assess the side effects of therapy, arm symptoms, breast symptoms, body image, and sexual function. Additionally, there are single items assessing sexual enjoyment, anxiety caused by hair loss, and future outlook. The scores range between 0-100 points. For scales evaluating function, a higher score represents a higher level of functioning. For scales evaluating symptoms, a higher score indicates more severe symptoms.
Changes from baseline in Functional capacity on the The Six-Minute Walk Test at 2 and 6 months.
The Six-Minute Walk Test determines the maximum distance (meters) that a person can walk in 6 minutes. The participants are instructed to set their own pace, to "walk as far as they can in 6 minutes", and to volitionally increase or decrease the speed during the test. Standardized phrases of encouragement are given.
Changes from baseline in Isometric handgrip strength on Hand-held Dynamometry at 2 and 6 months.
Using manual isometric dynamometry with adjustable grip in a standing position with elbow in complete extension. The test is performed 3 times per hand (alternating both hands), with a 1-minute rest between trials. The average score for each hand is registered.
Changes from baseline in Strength endurance deep cervical musculature on cranio-cervical flexion test at 2 and 6 months.
This test measures the strength of the deep flexor muscles of the neck. It consists of placing the patient in supine position with the spine fully supported on the stretcher and asking him to first, to do a flexion of the upper cervical spine and to simultaneously flex the lower cervical spine. The time that the patient is able to maintain the position without loosing the initial distance that separated him from the stretcher is counted.
Changes from baseline in Body composition by using electrical bioimpedance analysis at 2 and 6 months.
The electrical impedance analysis is used for estimating body composition, in particular body fat and muscle mass.
Changes from baseline in stress and inflammatory responses at 2 and 6 months.
Salivary Cortisol, Interleukin-6 and C-reactive protein biomarkers are analyzed.

Full Information

First Posted
March 18, 2021
Last Updated
May 8, 2023
Sponsor
Universidad de Granada
search

1. Study Identification

Unique Protocol Identification Number
NCT04877860
Brief Title
Pain Treatment in a Breast Cancer Population. PaiNEd Study.
Acronym
PaiNEd
Official Title
Effectiveness of an E-Health System Integrated in a Physical Recovery Program for the Treatment of Pain in the Oncological Population. PaiNEd Study.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 4, 2022 (Actual)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad de Granada

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objectives of this study are: 1) To design and implement the PaiNEd system for the evaluation and treatment based on Pain Neuroscience Education (PNE) in cancer survivors with sequelae derived from medical treatments; 2) Study the effectiveness of the PaiNEd system integrated in a multimodal physical recovery program compared to traditional biomedical information. This project aims to first carry out the design and implementation of an e-health system for the evaluation and treatment of pain. A randomized controlled experimental study will be carried out in which 72 breast cancer survivors will be recruited and randomly assigned to three study groups.
Detailed Description
People who have suffered cancer often do not find an adequate therapeutic response for the sequelae derived from its treatments. The objectives of this study are: 1) To design and implement the PaiNEd system for the evaluation and treatment based on Pain Neuroscience Education (PNE) in cancer survivors with sequelae derived from medical treatments; 2) Study the effectiveness of the PaiNEd system integrated in a multimodal physical recovery program compared to traditional biomedical information. In this regard, there is a shortage of proposals for certain subgroups of patients who demand special attention. This project aims to first carry out the design and implementation of an e-health system for the evaluation and treatment of pain. A randomized controlled experimental study will be carried out in which 72 breast cancer survivors will be recruited and randomly assigned to the three study groups: a) physical recovery program + access to the PaiNEd system; b) physical recovery program + traditional biomedical recommendations; c) control group. The evaluation will be carried out at baseline (at the beginning of the study), at 8 weeks (time of completion of the intervention) and at 6 months of follow-up of the patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
E-health, exercise, telehealth, telerehabilitation, pain management, cancer

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Experimental design with two intervention groups and a control group. Effectiveness study. Intervention group 1: multimodal rehabilitation program + PNE Intervention group 2: multimodal rehabilitation program + traditional biomedical information Control group: Patient waiting list.
Masking
ParticipantCare Provider
Masking Description
Participants who meet the inclusion criteria will be randomized into each of the groups using a random number generation program (EPIDAT 4.2, junta de Galicia). The sequence will be placed in an opaque envelope closed by a member outside the investigation and will be opened once the baseline assessment is completed, so the assessment staff will be masked for the randomization of the participants, thus reducing the risk of bias during the evaluation. The blinding of evaluators will be guaranteed by the fact that some members of the group are specialized in the treatment of cancer patients and others in their evaluation.
Allocation
Randomized
Enrollment
72 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Multimodal rehabilitation program + PNE (Therapeutic exercise, manual therapy and PNE)
Arm Type
Experimental
Arm Description
Physical recovery program (multimodal) with a duration of 8 weeks. Three weekly sessions on alternate days lasting 60 minutes each one. 4 individual manual therapy sessions (1 session every 2 weeks). Access to the PaiNEd system.
Arm Title
Multimodal rehabilitation program + traditional biomedical information
Arm Type
Active Comparator
Arm Description
Physical recovery program (multimodal) with a duration of 8 weeks. Three weekly sessions on alternate days lasting 60 minutes each one. 4 individual manual therapy sessions (1 session every 2 weeks). Dossier with traditional biomedical recommendations on the management of pain and disability.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Information dossier with recommendations on pain control and dysfunction improvement.
Intervention Type
Other
Intervention Name(s)
Multimodal rehabilitation program + PNE (Therapeutic exercise, manual therapy and PNE)
Intervention Description
The sessions will consist of therapeutic exercise in groups: a) warm-up (10 minutes aerobic exercise), b) active mobilizations (cervical / shoulder) c) strength exercises of the cervical and shoulder muscles + general conditioning d) active postural control e) stretching and relaxation exercises. 4 sessions of myofascial induction. Finally, patients will have access to the PaiNEd system before the start of the program (to prepare them for treatment sessions) and during the development of the treatment program in which they will introduce their pain levels and their characteristics and also receive a series of educational advice and recommendations for its improvement.
Intervention Type
Other
Intervention Name(s)
Multimodal rehabilitation program + traditional biomedical information
Intervention Description
The sessions will consist of therapeutic exercise in groups: a) warm-up (10 minutes aerobic exercise), b) active mobilizations (cervical / shoulder) c) strength exercises of the cervical and shoulder muscles + general conditioning d) active postural control e) stretching and relaxation exercises. 4 sessions of myofascial induction. Patients will receive a dossier with traditional biomedical recommendations on pain management and disability associated with the side effects of cancer treatment.
Intervention Type
Other
Intervention Name(s)
Control group
Intervention Description
Waiting list of patients who have agreed to participate in the study. They will receive an information dossier with recommendations on pain control and improvement of dysfunction (similar to what was worked on in the experimental group). These recommendations will be distributed at the beginning of the study (initial assessment) and they will be summoned at 8 weeks for the next collection of variables. All patients will be invited to participate in the experimental phase at the end of the control phase.
Primary Outcome Measure Information:
Title
Change from baseline in Pain on the Visual Analogue scale and Brief Pain Inventory at 2 and 6 months.
Description
The Visual Analogue Scale is used to assess the intensity of spontaneous neck, temporomandibular and shoulder pain. The VAS is a 100 mm line anchored with a '0' at one end representing no pain and '100' at the other end representing the worst pain imaginable.
Time Frame
Baseline, 2 and 6 months.
Secondary Outcome Measure Information:
Title
Changes from baseline in Pain Catastrophizing Scale at 2 and 6 months.
Description
Used to assess catastrophic thinking related to pain. Pain catastrophizing scale is a 13-item self-reported questionnaire. Patients rate how frequent they experience each of 13 items or types of pain experience. It uses a 5-point Likert scale, from 0 (mild symptoms) to 4 (worst symptoms). The total score is derived from the sum of the individual scores for the 13 items. The higher the total score, the more the patient exhibits pain catastrophizing characteristics.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Central Sensitization Inventory (CSI) at 2 and 6 months.
Description
Used to assess if participants have symptoms that may be related to central sensitisation. The Central Sensitization Inventory (CSI) is composed of two different parts. The first one consists of 25 statements, each answer is scored: 0 Never, 1 Rarely, 2 Sometimes, 3 Often, and 4 Always. So that, at most we will be able to obtain a score of 100 and a minimum of 0. The second part is a survey in which patients explain if they have been diagnosed of specific disorders. Higher CSI scores mean greater symptoms of central sensitization. If patients obtain a score greater than or equal to 40, we will consider that they have sufficient psychometrics to be correlated with central sensitization syndromes
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Kinesiophobia on the Tampa Scale for Kinesiophobia (TSK-11) at 2 and 6 months.
Description
Kinesiophobia will be measured by an 11-item version of the Tampa Scale for Kinesiophobia (TSK-11). Each item has 4 response options, "strongly disagree" scores 1 point, and "strongly agree" scores 4 points. The maximum possible score is 44 points and the minimum is 11 points. Greater scores mean strong fear of movement.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Active shoulder and cervical spine on goniometry at 2 and 6 months.
Description
A plastic universal goniometer with two adjustable overlapping arms is used to objectively measure the active range of motion of the shoulder joint. An inclinometer device is used to objectively measure the active range of motion of the cervical joints.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Quality of life on The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire at 2 and 6 months.
Description
This questionnaire is a breast cancer module of the The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire that contains 23 items rated on a four-point scale ranging from 1 (not at all) to 4 (very much). The items assess the side effects of therapy, arm symptoms, breast symptoms, body image, and sexual function. Additionally, there are single items assessing sexual enjoyment, anxiety caused by hair loss, and future outlook. The scores range between 0-100 points. For scales evaluating function, a higher score represents a higher level of functioning. For scales evaluating symptoms, a higher score indicates more severe symptoms.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Functional capacity on the The Six-Minute Walk Test at 2 and 6 months.
Description
The Six-Minute Walk Test determines the maximum distance (meters) that a person can walk in 6 minutes. The participants are instructed to set their own pace, to "walk as far as they can in 6 minutes", and to volitionally increase or decrease the speed during the test. Standardized phrases of encouragement are given.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Isometric handgrip strength on Hand-held Dynamometry at 2 and 6 months.
Description
Using manual isometric dynamometry with adjustable grip in a standing position with elbow in complete extension. The test is performed 3 times per hand (alternating both hands), with a 1-minute rest between trials. The average score for each hand is registered.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Strength endurance deep cervical musculature on cranio-cervical flexion test at 2 and 6 months.
Description
This test measures the strength of the deep flexor muscles of the neck. It consists of placing the patient in supine position with the spine fully supported on the stretcher and asking him to first, to do a flexion of the upper cervical spine and to simultaneously flex the lower cervical spine. The time that the patient is able to maintain the position without loosing the initial distance that separated him from the stretcher is counted.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in Body composition by using electrical bioimpedance analysis at 2 and 6 months.
Description
The electrical impedance analysis is used for estimating body composition, in particular body fat and muscle mass.
Time Frame
Baseline, 2 and 6 months.
Title
Changes from baseline in stress and inflammatory responses at 2 and 6 months.
Description
Salivary Cortisol, Interleukin-6 and C-reactive protein biomarkers are analyzed.
Time Frame
Baseline, 2 and 6 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects over 18 years of age. Having undergone surgery and finished adjuvant treatment (radiotherapy and / or chemotherapy) six months or two years ago. Not having active cancer. Having pain in the regions related to the tumor area (cervical and / or brachial and / or shoulder), pain ≥ 4 (VAS 0 to 10) for> 4 weeks Present musculoskeletal or functional alterations in the previous regions. Exclusion Criteria: Identification by the research team of physical or mental impossibility to carry out the tests of the study. Suffering from chronic pain or having suffered a previous trauma to the spine, head, temporomandibular joint or upper extremities.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Carolina Fernández Lao, PhD
Phone
958248037
Ext
+34
Email
carolinafl@ugr.es
First Name & Middle Initial & Last Name or Official Title & Degree
Patrocinio Ariza Vega, PhD
Phone
958248032
Ext
+34
Email
pariza@ugr.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carolina Fernández Lao, PhD
Organizational Affiliation
Health Sciences Faculty, University of Granada
Official's Role
Study Director
Facility Information:
Facility Name
Health Sciences Faculty, University of Granada
City
Granada
ZIP/Postal Code
18071
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carolina Fernández Lao, PhD
Phone
958248037
Ext
+34
Email
carolinafl@ugr.es
First Name & Middle Initial & Last Name & Degree
Patrocinio Ariza Vega, PhD
Phone
958248729
Ext
+34
Email
pariza@ugr.es

12. IPD Sharing Statement

Learn more about this trial

Pain Treatment in a Breast Cancer Population. PaiNEd Study.

We'll reach out to this number within 24 hrs